|In a recent article by The Economist, a simple question was asked: Why has cancer not been cured? Despite a forty year war against the disease, that questions has no simple answer. Research has taught us that more than a mutation of genes, cancer is a disease of specific organs. New therapies are increasingly providing personalized solutions to harness the body’s own immune system in fighting cancer, but more still needs to be understood about the molecular mechanisms that drive it.
On September 28th in Boston at the War on Cancer conference, editors of The Economist will gather more than 200 global health-care players, including Flatiron Health, Memorial Sloan Kettering, IBM, MD Anderson Cancer Center and others to discuss the technological advancements improving our ability to fight cancer and expand access to targeted, quality cancer care.
Some of our notable speakers participating in the event include:
- Amy Abernethy, Chief medical officer and senior vice-president of oncology, Flatiron Health
- Christina Åkerman, President, International Consortium For Health Outcomes Measurement (ICHOM)
- Peter Bach, Director, center for health policy and outcomes, Memorial Sloan Kettering
- Amitabh Chandra, Director, health policy research, Harvard Kennedy School of Government
- Kathleen Kaa, Global head of pricing and market access, Oncology, Roche
- Kyu Rhee, Chief health officer, IBM
You can save 15% on the current available rate when you register with our special code: CHI15